disease
-
Spine
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company…
Read More » -
Biologics
BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
–Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— –15 Clinical Sites Identified, 12…
Read More » -
Biologics
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
—Clinical data expected to be reviewed by independent data safety monitoring board (DSMB) as to initial safety dosing profile of BRTX-100– MELVILLE,…
Read More » -
Biologics
BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
First Patient Enrollment Milestone Completed MELVILLE, NY., June 30, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
MELVILLE, NY., June 22, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
— First Site Will Enroll First Patient in the Clinical Study– MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies,…
Read More » -
Spine
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company…
Read More » -
COVID-19
This Policy Expert Explains Why The United States Will See An Increase In Non-Coronavirus Deaths (And How We Can Stop It)
April 8, 2020 / Anand Parekh, Contributor Coronavirus Frontlines is a special series where we are sharing the perspective of…
Read More » -
COVID-19
Why Some COVID-19 Patients Crash: The Body’s Immune System Might Be To Blame
April 7, 2020 / GEOFF BRUMFIEL It’s a strange and tragic pattern in some cases of COVID-19: The patient struggles…
Read More » -
COVID-19
8 strains of the coronavirus are circling the globe. Here’s what clues they’re giving scientists
March 27, 2020 / Elizabeth Weise, USA TODAY SAN FRANCISCO — At least eight strains of the coronavirus are making their way…
Read More » -
COVID-19
Will ‘herd immunity’ work against coronavirus?
March 23, 2020 / By Hollie McKay | Fox News As the novel coronavirus spreads through much of the globe, the debate over the…
Read More » -
COVID-19
Surgeon General has coronavirus warning: ‘This week, it’s going to get bad’
March 23, 2020 / By Rebecca Shabad WASHINGTON — Surgeon General Dr. Jerome Adams warned Monday that the coronavirus outbreak will worsen this…
Read More » -
COVID-19
Johnson & Johnson Says There’s Insufficient Evidence Its HIV Drug Can Treat COVID-19
March 16, 2020 / David Jagielski Johnson & Johnson (NYSE:JNJ) released a statement on Monday that said there wasn’t sufficient evidence to…
Read More » -
Biologics
When will a coronavirus vaccine be ready?
Mon 16 Mar 2020 / Laura Spinney Even at their most effective – and draconian – containment strategies have only…
Read More » -
OSN Premium
Technology Tricks Body into Healing
by Elizabeth Hofheinz, M.P.H., M.Ed., October 29, 2019 It is sometimes said that you can fool the mind, but not…
Read More »